.png){kind=icon}
.png){kind=icon}
Return
Recent Progress in Glucose-Responsive Insulin
.png){kind=icon}
PRE
AI
DOI：10.2337/dbi23-0028.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Insulin replacement therapy is indispensable in the treatment of type 1 and advanced type 2 diabetes. However, insulin's clinical application is challenging due to its narrow therapeutic index. To mitigate acute and chronic risks of glucose excursions, glucose-responsive insulin (GRI) has long been pursued for clinical application. By integrating GRI with glucose-sensitive elements, GRI is capable of releasing or activating insulin in response to plasma or interstitial glucose levels without external monitoring, thereby improving glycemic control and reducing hypoglycemic risk. In this Perspective, we first introduce the history of GRI development and then review major glucose-responsive components that can be leveraged to control insulin delivery. Subsequently, we highlight the recent advances in GRI delivery carriers and insulin analogs. Finally, we provide a look to the future and the challenges of clinical application of GRI.
Keywords:
SENSITIVE VESICLES
BETA-CELLS
HYDROGELS
DELIVERY
HYPOXIA
COMPLEX
PATCHES
Journal
IF:
7.5
Papers:
2.6W
Citations:
4.6W